The FDA has extended the comment period until Sept. 17 on its draft labeling guidance addressing use of the name “potassium chloride salt” in place of “potassium chloride.” The draft guidance, when finalized, will explain the FDA’s intent to exercise enforcement discretion for the declaration of the name “potassium chloride salt,” as an alternative to the more common or usual ... Read More